Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Sep-Oct;27(5):315-25.
doi: 10.1016/s0147-9563(98)90052-8.

Symptom experience associated with maintenance immunosuppression after heart transplantation: patients' appraisal of side effects

P Moons  1 , S De Geest, I Abraham, J V Cleemput, J Van Vanhaecke
Affiliations

Symptom experience associated with maintenance immunosuppression after heart transplantation: patients' appraisal of side effects

P Moons et al. Heart Lung. 1998 Sep-Oct.

Abstract

Objective: To evaluate symptom experience related to side effects of immunosuppressive therapy in heart transplant recipients.

Methods: This descriptive, cross-sectional study included 105 heart transplant recipients (90 men; 15 women) with a median age of 56 years. Maintenance immunosuppression consisted of triple therapy (cyclosporine, corticosteroids, azathioprine). Symptom frequency and symptom distress were assessed by an adapted version of the Transplant Symptom Frequency and Symptom Distress Scale, which includes 27 symptoms associated with side effects of immunosuppressive therapy.

Results: The most frequent symptom for both sexes was increased hair growth. Impotence and painful menstruation were experienced as the most distressing symptoms for men and women, respectively. Women reported a significantly higher level of symptom experience. The majority of the most frequent and most distressing symptoms were corticosteroid associated.

Conclusions: Patients' perception of side effects completes the symptomatologic profile of immunosuppressive therapy. A gender-specific evaluation is indicated because symptom experience differs between the sexes.

PubMed Disclaimer

Publication types